278 related articles for article (PubMed ID: 28440002)
21. Capsaicin-sensitive C- and A-fibre nociceptors control long-term potentiation-like pain amplification in humans.
Henrich F; Magerl W; Klein T; Greffrath W; Treede RD
Brain; 2015 Sep; 138(Pt 9):2505-20. PubMed ID: 25943423
[TBL] [Abstract][Full Text] [Related]
22. Neurogenic hyperalgesia: central neural correlates in responses of spinothalamic tract neurons.
Simone DA; Sorkin LS; Oh U; Chung JM; Owens C; LaMotte RH; Willis WD
J Neurophysiol; 1991 Jul; 66(1):228-46. PubMed ID: 1919669
[TBL] [Abstract][Full Text] [Related]
23. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.
Sang CN; Hostetter MP; Gracely RH; Chappell AS; Schoepp DD; Lee G; Whitcup S; Caruso R; Max MB
Anesthesiology; 1998 Nov; 89(5):1060-7. PubMed ID: 9821993
[TBL] [Abstract][Full Text] [Related]
24. Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin.
Carmichael NME; Dostrovsky JO; Charlton MP
Pain; 2010 May; 149(2):316-324. PubMed ID: 20223589
[TBL] [Abstract][Full Text] [Related]
25. Secondary hyperalgesia to mechanical but not heat stimuli following a capsaicin injection in hairy skin.
Ali Z; Meyer RA; Campbell JN
Pain; 1996 Dec; 68(2-3):401-11. PubMed ID: 9121830
[TBL] [Abstract][Full Text] [Related]
26. A randomized, double-blind, crossover study to evaluate the depth response relationship of intradermal capsaicin-induced pain and hyperalgesia in healthy adult volunteers.
Silberberg A; Moeller-Bertram T; Wallace MS
Pain Med; 2015 Apr; 16(4):745-52. PubMed ID: 25530160
[TBL] [Abstract][Full Text] [Related]
27. Two types of C nociceptors in human skin and their behavior in areas of capsaicin-induced secondary hyperalgesia.
Serra J; Campero M; Bostock H; Ochoa J
J Neurophysiol; 2004 Jun; 91(6):2770-81. PubMed ID: 14762154
[TBL] [Abstract][Full Text] [Related]
28. Bilateral hypersensitivity to capsaicin, thermal, and mechanical stimuli in unilateral complex regional pain syndrome.
Terkelsen AJ; Gierthmühlen J; Finnerup NB; Højlund AP; Jensen TS
Anesthesiology; 2014 May; 120(5):1225-36. PubMed ID: 24621686
[TBL] [Abstract][Full Text] [Related]
29. Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.
Mainka T; Malewicz NM; Baron R; Enax-Krumova EK; Treede RD; Maier C
Eur J Pain; 2016 Jan; 20(1):116-29. PubMed ID: 25854794
[TBL] [Abstract][Full Text] [Related]
30. A human model of intraoral pain and heat hyperalgesia.
Baad-Hansen L; Jensen TS; Svensson P
J Orofac Pain; 2003; 17(4):333-40. PubMed ID: 14737878
[TBL] [Abstract][Full Text] [Related]
31. Short lasting transient effects of a capsaicin 8% patch on nociceptor activation in humans.
Landmann G; Lustenberger C; Schleinzer W; Schmelz M; Stockinger L; Rukwied R
Eur J Pain; 2016 Oct; 20(9):1443-53. PubMed ID: 26988467
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
Schulte-Mattler WJ; Opatz O; Blersch W; May A; Bigalke H; Wohlfahrt K
J Neurol Sci; 2007 Sep; 260(1-2):38-42. PubMed ID: 17481662
[TBL] [Abstract][Full Text] [Related]
33. Response properties of dorsal root reflexes in cutaneous C fibers before and after intradermal capsaicin injection in rats.
Weng HR; Dougherty PM
Neuroscience; 2005; 132(3):823-31. PubMed ID: 15837142
[TBL] [Abstract][Full Text] [Related]
34. Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
Zhang X; Strassman AM; Novack V; Brin MF; Burstein R
Cephalalgia; 2016 Aug; 36(9):875-86. PubMed ID: 26984967
[TBL] [Abstract][Full Text] [Related]
35. Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia.
Wallace MS; Laitin S; Licht D; Yaksh TL
Anesthesiology; 1997 Jun; 86(6):1262-72. PubMed ID: 9197294
[TBL] [Abstract][Full Text] [Related]
36. Nonparalytic botulinum molecules for the control of pain.
Mangione AS; Obara I; Maiarú M; Geranton SM; Tassorelli C; Ferrari E; Leese C; Davletov B; Hunt SP
Pain; 2016 May; 157(5):1045-1055. PubMed ID: 26761389
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin A increases analgesic effects of morphine, counters development of morphine tolerance and modulates glia activation and μ opioid receptor expression in neuropathic mice.
Vacca V; Marinelli S; Luvisetto S; Pavone F
Brain Behav Immun; 2013 Aug; 32():40-50. PubMed ID: 23402794
[TBL] [Abstract][Full Text] [Related]
38. Effects of topical capsaicin on normal skin and affected dermatomes in herpes zoster.
Westerman RA; Roberts RG; Kotzmann RR; Westerman DA; Delaney C; Widdop RE; Carter BE
Clin Exp Neurol; 1988; 25():71-84. PubMed ID: 3267488
[TBL] [Abstract][Full Text] [Related]
39. Early and late effects of prolonged topical capsaicin on cutaneous sensibility and neurogenic vasodilatation in humans.
Simone DA; Ochoa J
Pain; 1991 Dec; 47(3):285-294. PubMed ID: 1784499
[TBL] [Abstract][Full Text] [Related]
40. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms.
LaMotte RH; Shain CN; Simone DA; Tsai EF
J Neurophysiol; 1991 Jul; 66(1):190-211. PubMed ID: 1919666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
